| - GRCh37:
- Chr6:160482952
- GRCh38:
- Chr6:160061920
| IGF2R | Q1192* | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr5:128302282-128302283
- GRCh38:
- Chr5:128966589-128966590
| SLC27A6 | C151* | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr16:396754-396766
- GRCh38:
- Chr16:346754-346766
| AXIN1 | E87fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr16:396748-396751
- GRCh38:
- Chr16:346748-346751
| AXIN1 | L92fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr5:112137010-112137011
- GRCh38:
- Chr5:112801313-112801314
| APC | D197fs, D228fs, D231fs, D238fs, D256fs, D266fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr4:155505974-155505976
- GRCh38:
- Chr4:154584822-154584824
| FGA | D634del | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195506731-195506826
- GRCh38:
- Chr3:195779860-195779955
| MUC4 | | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr1:27099103
- GRCh38:
- Chr1:26772612
| ARID1A, LOC126805670 | P1175fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:21230419-21230421
- GRCh38:
- Chr2:21007547-21007549
| APOB | N3107del | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr4:74275083-74275087
- GRCh38:
- Chr4:73409366-73409370
| ALB | E165fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr4:74275079-74275081
- GRCh38:
- Chr4:73409362-73409364
| ALB | Y164del | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195509192-195509287
- GRCh38:
- Chr3:195782321-195782416
| MUC4 | | Lung cancer, Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195508587-195508634
- GRCh38:
- Chr3:195781716-195781763
| MUC4 | | Lung cancer, Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195508546-195508562
- GRCh38:
- Chr3:195781675-195781691
| MUC4 | L3297fs, L4871fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr10:29843733
- GRCh38:
- Chr10:29554804
| SVIL | D47H | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr5:139228065-139228066
- GRCh38:
- Chr5:139848480-139848481
| NRG2 | P598fs, P658fs, P664fs, P666fs, P672fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr12:46246515
- GRCh38:
- Chr12:45852732
| ARID2 | R1537* | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195513639-195513686
- GRCh38:
- Chr3:195786768-195786815
| MUC4 | | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr19:10610202-10610268
- GRCh38:
- Chr19:10499526-10499592
| KEAP1 | G148fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195510125-195510217
- GRCh38:
- Chr3:195783254-195783346
| MUC4 | | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195506827-195506922
- GRCh38:
- Chr3:195779956-195780051
| MUC4 | | Lung cancer, Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- ChrX:151138867
- GRCh38:
- ChrX:151970395
| GABRE | G22* | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr12:46285579-46285586
- GRCh38:
- Chr12:45891796-45891803
| ARID2 | S1647fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr4:155507905-155507906
- GRCh38:
- Chr4:154586753-154586754
| FGA | K225fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195509756-195509757
- GRCh38:
- Chr3:195782885-195782886
| MUC4 | | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:640042-640043
- GRCh38:
- Chr11:640042-640043
| DRD4 | | Lung cancer, Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:640004-640099
- GRCh38:
- Chr11:640004-640099
| DRD4 | | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195508101-195508102
- GRCh38:
- Chr3:195781230-195781231
| MUC4 | | Lung cancer, Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr1:27088734
- GRCh38:
- Chr1:26762243
| ARID1A | H782fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195508454-195508455
- GRCh38:
- Chr3:195781583-195781584
| MUC4 | | Hepatocellular carcinoma, Lung cancer | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195508020-195508025
- GRCh38:
- Chr3:195781149-195781154
| MUC4 | | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr1:26608812-26608889
- GRCh38:
- Chr1:26282321-26282398
| UBXN11 | | Hepatocellular carcinoma, Lung cancer, Small cell lung carcinoma
| Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195511494-195511637
- GRCh38:
- Chr3:195784623-195784766
| MUC4 | | Lung cancer, Hepatocellular carcinoma, Small cell lung carcinoma
| Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr10:29812947
- GRCh38:
- Chr10:29524018
| SVIL | G440*, G472*, G556*, G866* | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195509879-195509974
- GRCh38:
- Chr3:195783008-195783103
| MUC4 | | Lung cancer, Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr5:139422408
- GRCh38:
- Chr5:140042823
| NRG2 | A83fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195513398-195513399
- GRCh38:
- Chr3:195786527-195786528
| MUC4 | | Lung cancer, Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195507193-195507194
- GRCh38:
- Chr3:195780322-195780323
| MUC4 | | Hepatocellular carcinoma, Small cell lung carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:640099-640100
- GRCh38:
- Chr11:640099-640100
| DRD4 | S284fs | Lung cancer, Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195506117-195506118
- GRCh38:
- Chr3:195779246-195779247
| LOC126806930, MUC4 | | Lung cancer, Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr16:396989
- GRCh38:
- Chr16:346989
| AXIN1 | G13* | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195510198-195510341
- GRCh38:
- Chr3:195783327-195783470
| MUC4 | | Lung cancer, Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr4:74276071-74276072
- GRCh38:
- Chr4:73410354-73410355
| ALB | R221fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195513398-195513399
- GRCh38:
- Chr3:195786527-195786528
| MUC4 | | Lung cancer, Hepatocellular carcinoma, Small cell lung carcinoma
| Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195508188-195508189
- GRCh38:
- Chr3:195781317-195781318
| MUC4 | | Lung cancer, Hepatocellular carcinoma, Small cell lung carcinoma
| Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr12:46245082-46245083
- GRCh38:
- Chr12:45851299-45851300
| ARID2 | L1059fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195512597-195512598
- GRCh38:
- Chr3:195785726-195785727
| MUC4 | | Lung cancer, Hepatocellular carcinoma, Small cell lung carcinoma
| Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195509894-195509987
- GRCh38:
- Chr3:195783023-195783116
| MUC4 | A2822fs, A4091fs | Lung cancer, Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195508647-195508790
- GRCh38:
- Chr3:195781776-195781919
| MUC4 | | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr1:144952581
- GRCh38:
- Chr1:148931908
| PDE4DIP | I109M, I112M, I138M, I159M, I175M, I209M, I246M, I77M | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195507242-195507243
- GRCh38:
- Chr3:195780371-195780372
| MUC4 | | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195513413-195513414
- GRCh38:
- Chr3:195786542-195786543
| MUC4 | | Lung cancer, Hepatocellular carcinoma, Small cell lung carcinoma
| Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195512597-195512598
- GRCh38:
- Chr3:195785726-195785727
| MUC4 | | Lung cancer, Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195509420-195509515
- GRCh38:
- Chr3:195782549-195782644
| MUC4 | | Lung cancer, Hepatocellular carcinoma, Small cell lung carcinoma
| Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195508166-195508261
- GRCh38:
- Chr3:195781295-195781390
| MUC4 | | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr6:170871055-170871070
- GRCh38:
- Chr6:170561967-170561982
| LOC108663996, TBP | Q57fs, Q77fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195514998-195515141
- GRCh38:
- Chr3:195788127-195788270
| MUC4 | | Lung cancer, Hepatocellular carcinoma, Small cell lung carcinoma
| Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195510749-195510750
- GRCh38:
- Chr3:195783878-195783879
| MUC4 | | Lung cancer, Hepatocellular carcinoma, Small cell lung carcinoma
| Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195509476-195509477
- GRCh38:
- Chr3:195782605-195782606
| MUC4 | | Lung cancer, Hepatocellular carcinoma, Small cell lung carcinoma
| Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr19:501701-501702
- GRCh38:
- Chr19:501701-501702
| MADCAM1, MADCAM1-AS1 | | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195507262-195507263
- GRCh38:
- Chr3:195780391-195780392
| MUC4 | | Hepatocellular carcinoma, Small cell lung carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195507242-195507243
- GRCh38:
- Chr3:195780371-195780372
| MUC4 | | Lung cancer, Hepatocellular carcinoma, Small cell lung carcinoma
| Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr4:88536979-88536980
- GRCh38:
- Chr4:87615827-87615828
| DSPP | N1056fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr6:170871055-170871079
- GRCh38:
- Chr6:170561967-170561991
| LOC108663996, TBP | Q57fs, Q77fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195506196-195506197
- GRCh38:
- Chr3:195779325-195779326
| LOC126806930, MUC4 | | Lung cancer, Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr1:27106284-27106291
- GRCh38:
- Chr1:26779793-26779800
| ARID1A | P1749fs, P1966fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195507858-195507859
- GRCh38:
- Chr3:195780987-195780988
| MUC4 | | Lung cancer, Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195507762-195507763
- GRCh38:
- Chr3:195780891-195780892
| MUC4 | | Lung cancer, Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr16:396693
- GRCh38:
- Chr16:346693
| AXIN1 | C111* | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- ChrX:151131073
- GRCh38:
- ChrX:151962601
| GABRE | E129* | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195511576-195511671
- GRCh38:
- Chr3:195784705-195784800
| MUC4 | | Lung cancer, Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195511239-195511334
- GRCh38:
- Chr3:195784368-195784463
| MUC4 | | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195510749-195510750
- GRCh38:
- Chr3:195783878-195783879
| MUC4 | | Hepatocellular carcinoma, Lung cancer | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195509375-195509518
- GRCh38:
- Chr3:195782504-195782647
| MUC4 | | Hepatocellular carcinoma, Lung cancer | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr19:501743-501744
- GRCh38:
- Chr19:501743-501744
| MADCAM1, MADCAM1-AS1 | | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr5:139422565-139422567
- GRCh38:
- Chr5:140042980-140042982
| NRG2 | S30del | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr16:67304692
- GRCh38:
- Chr16:67270789
| SLC9A5 | C461fs, C462fs, C656fs, C756fs, C757fs, V632fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr16:67304683
- GRCh38:
- Chr16:67270780
| SLC9A5 | P629A, S458C, S459C, S653C, S753C, S754C | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr7:45928483
- GRCh38:
- Chr7:45888884
| IGFBP1 | C78G | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr6:160430165
- GRCh38:
- Chr6:160009133
| IGF2R | L138Q | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:7579578
- GRCh38:
- Chr17:7676260
| TP53 | S37fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr1:144879387
- GRCh38:
- Chr1:149005085
| PDE4DIP | R1310*, R1311*, R1355*, R1381*, R1384*, R1407*, R1420*, R1421*, R1455*, R1491*, R1492*, R1517*, R1518* | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr16:29996541
- GRCh38:
- Chr16:29985220
| TAOK2 | R477L | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr5:112178637
- GRCh38:
- Chr5:112842940
| APC | S2065I, S2166I, S2289I, S2320I, S2323I, S2348I, S2358I, S2366I, S2390I, S2408I, S2421I, S2424I, S2431I, S2439I, S2442I, S2449I, S2459I, S2467I, S2477I | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr22:29445819-29445821
- GRCh38:
- Chr22:29049831-29049833
| ZNRF3 | S457del, S557del | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195506713-195506760
- GRCh38:
- Chr3:195779842-195779889
| MUC4 | | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr4:88537073-88537126
- GRCh38:
- Chr4:87615921-87615974
| DSPP | | Hepatocellular carcinoma, Lung cancer | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr19:10610198
- GRCh38:
- Chr19:10499522
| KEAP1 | C171Y | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr5:139422532-139422534
- GRCh38:
- Chr5:140042947-140042949
| NRG2 | S41del | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr16:347855
- GRCh38:
- Chr16:297855
| AXIN1 | E551* | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr12:46231337
- GRCh38:
- Chr12:45837554
| ARID2 | E393* | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:21233559
- GRCh38:
- Chr2:21010687
| APOB | D2061Y | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195510230
- GRCh38:
- Chr3:195783359
| MUC4 | D3962fs, E2741fs | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr4:88537105-88537107
- GRCh38:
- Chr4:87615953-87615955
| DSPP | D1098del | Hepatocellular carcinoma, Lung cancer | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195515258-195515353
- GRCh38:
- Chr3:195788387-195788482
| MUC4 | | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr22:20918817-20918819
- GRCh38:
- Chr22:20564530-20564532
| MED15 | Q117del, Q162del, Q188del | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195511448-195511590
- GRCh38:
- Chr3:195784577-195784719
| MUC4 | P2288fs, P3349fs | Lung cancer, Hepatocellular carcinoma, Small cell lung carcinoma
| Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:195511446
- GRCh38:
- Chr3:195784575
| MUC4 | P2336fs, P3397fs | Hepatocellular carcinoma, Small cell lung carcinoma, Lung cancer
| Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr9:33385808
- GRCh38:
- Chr9:33385810
| AQP7 | N137K, N193K, N194K | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:132237732
- GRCh38:
- Chr2:131480159
| MZT2A, TUBA3D | R156W | Hepatocellular carcinoma | Pathogenic (Jun 15, 2021) | no assertion criteria provided |